Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer
暂无分享,去创建一个
J. Raats | A. Theron | Jacqueline M. Hall | Sze-Wai Chan | D. Vorobiof | T. Smit | R. V. Van Eeden | R. Anderson | M. D. Necker | L. Langenhoven | Bernardo L Rapoport | M. C. Botha | R. van Eeden